Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 100

1.

Problems of nephrooncology. Proceedings from the 1st Scientific and Training Conference Nephrooncology 5-6 October 2018, Gdańsk, Poland.

Bączkowska T, Bissler JJ, Błasińska‑Przerwa K, Borawski J, Chudek J, Ciechanowski K, Czarkowska‑Pączek B, Dębska-Ślizień A, Domański M, Durlik M, Gellert R, Gozdowska J, Goździk M, Imko‑Walczuk B, Janiszewski J, Januszko‑Giergielewicz B, Jeśkiewicz M, Jóźwiak S, Kadylak D, Klinger M, Kosieradzki M, Kotulska K, Kozak Ł, Król E, Krzanowska K, Kurnatowska I, Labij‑Reduta B, Lichodziejewska‑Niemierko M, Lizakowski S, Małyszko J, Matuszewski M, Mazurkiewicz J, Mełeń‑Mucha G, Myślak M, Naumnik B, Nowicki M, Oko A, Pączek L, Perkowska-Ptasińska A, Piątak M, Piecha G, Radzikowska E, Renke M, Rutkowska B, Sawosz M, Skutecki R, Słowińska M, Sosińska‑Mielcarek K, Szafran‑Dobrowolska J, Szołkowska M, Szczepulska‑Wójcik E, Szurowska E, Tarasewicz A, Wągrowska‑Danilewicz M, Wołowiec D, Woźniak J, Zawiasa‑Bryszewska A.

Pol Arch Intern Med. 2019 May 2;129(Spec. Issue 2):1-74. doi: 10.20452/pamw.14821. Epub 2019 May 2. No abstract available.

2.

Distinctive features of lincRNA gene expression suggest widespread RNA-independent functions.

Tuck AC, Natarajan KN, Rice GM, Borawski J, Mohn F, Rankova A, Flemr M, Wenger A, Nutiu R, Teichmann S, Bühler M.

Life Sci Alliance. 2018 Jul 31;1(4):e201800124. doi: 10.26508/lsa.201800124. eCollection 2018 Aug.

3.

Toll-like receptor activation as a biomarker in traumatically injured patients.

Darrabie MD, Cheeseman J, Limkakeng AT, Borawski J, Sullenger BA, Elster EA, Kirk AD, Lee J.

J Surg Res. 2018 Nov;231:270-277. doi: 10.1016/j.jss.2018.05.059. Epub 2018 Jun 23.

PMID:
30278940
4.

Unexpected Cardiac MRI Findings in Patients Presenting to the Emergency Department for Possible Acute Coronary Syndrome.

Ziegler CE, Painter DM, Borawski JB, Kim RJ, Kim HW, Limkakeng AT Jr.

Crit Pathw Cardiol. 2018 Sep;17(3):167-171. doi: 10.1097/HPC.0000000000000148.

PMID:
30044259
5.

Effects of Enoxaparin on Intravascular Sclerostin Release in Healthy Men.

Borawski J, Zoltko J, Labij-Reduta B, Koc-Zorawska E, Naumnik B.

J Cardiovasc Pharmacol Ther. 2018 Jul;23(4):344-349. doi: 10.1177/1074248418770623. Epub 2018 Apr 15.

PMID:
29658328
6.

Care of the Patient with Chest Pain in the Observation Unit.

Borawski JB, Graff LG, Limkakeng AT.

Emerg Med Clin North Am. 2017 Aug;35(3):535-547. doi: 10.1016/j.emc.2017.03.003. Review.

PMID:
28711123
7.

Unexpected and striking effect of heparin-free dialysis on cytokine release.

Rydzewska-Rosolowska A, Gozdzikiewicz-Lapinska J, Borawski J, Koc-Zorawska E, Mysliwiec M, Naumnik B.

Int Urol Nephrol. 2017 Aug;49(8):1447-1452. doi: 10.1007/s11255-017-1589-8. Epub 2017 Apr 19.

8.

Critical Care Air Transport Team severe traumatic brain injury short-term outcomes during flight for Operation Iraqi Freedom/Operation Enduring Freedom.

Boyd LR, Borawski J, Lairet J, Limkakeng AT Jr.

J R Army Med Corps. 2017 Oct;163(5):342-346. doi: 10.1136/jramc-2016-000743. Epub 2017 Apr 6.

PMID:
28385926
9.

Extracellular superoxide dismutase release by enoxaparin and sparing effect of heparin-grafted hemodialyzer.

Borawski J, Gozdzikiewicz-Lapinska J, Naumnik B.

Hemodial Int. 2015 Oct;19(4):614-6. doi: 10.1111/hdi.12308. Epub 2015 Apr 28. No abstract available.

PMID:
25923146
10.

Effects of enoxaparin on myeloperoxidase release during hemodialysis.

Gozdzikiewicz J, Borawski J, Koc-Zorawska E, Mysliwiec M.

Hemodial Int. 2014 Oct;18(4):819-24. doi: 10.1111/hdi.12177. Epub 2014 May 19.

PMID:
24837008
11.

Small molecule-facilitated degradation of ANO1 protein: a new targeting approach for anticancer therapeutics.

Bill A, Hall ML, Borawski J, Hodgson C, Jenkins J, Piechon P, Popa O, Rothwell C, Tranter P, Tria S, Wagner T, Whitehead L, Gaither LA.

J Biol Chem. 2014 Apr 18;289(16):11029-41. doi: 10.1074/jbc.M114.549188. Epub 2014 Mar 5.

12.

Thrombolysis in myocardial infarction risk score in an observation unit setting.

Chavez J, Srinivasan A, Ely S, Drake W, Freeman D, Borawski J, Chandra A, Limkakeng AT Jr.

Crit Pathw Cardiol. 2013 Sep;12(3):137-40. doi: 10.1097/HPC.0b013e3182998bc1.

PMID:
23892944
13.

Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling.

Britschgi A, Bill A, Brinkhaus H, Rothwell C, Clay I, Duss S, Rebhan M, Raman P, Guy CT, Wetzel K, George E, Popa MO, Lilley S, Choudhury H, Gosling M, Wang L, Fitzgerald S, Borawski J, Baffoe J, Labow M, Gaither LA, Bentires-Alj M.

Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):E1026-34. doi: 10.1073/pnas.1217072110. Epub 2013 Feb 19.

14.

Dental visits to a North Carolina emergency department: a painful problem.

Hocker MB, Villani JJ, Borawski JB, Evans CS, Nelson SM, Gerardo CJ, Limkakeng AT.

N C Med J. 2012 Sep-Oct;73(5):346-51.

PMID:
23189415
15.

FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor.

Guagnano V, Kauffmann A, Wöhrle S, Stamm C, Ito M, Barys L, Pornon A, Yao Y, Li F, Zhang Y, Chen Z, Wilson CJ, Bordas V, Le Douget M, Gaither LA, Borawski J, Monahan JE, Venkatesan K, Brümmendorf T, Thomas DM, Garcia-Echeverria C, Hofmann F, Sellers WR, Graus-Porta D.

Cancer Discov. 2012 Dec;2(12):1118-33. doi: 10.1158/2159-8290.CD-12-0210. Epub 2012 Sep 20.

16.

Is xerostomia a risk factor for cardiovascular morbidity and mortality in maintenance hemodialysis patients?

Wilczynska-Borawska M, Baginska J, Borawski J.

Med Hypotheses. 2012 Oct;79(4):544-8. doi: 10.1016/j.mehy.2012.07.016. Epub 2012 Aug 6.

PMID:
22874451
17.

Hepatocyte growth factor in saliva of patients with renal failure and periodontal disease.

Wilczyńska-Borawska M, Borawski J, Bagińska J, Małyszko J, Myśliwiec M.

Ren Fail. 2012;34(8):942-51. doi: 10.3109/0886022X.2012.696510. Epub 2012 Jul 26.

PMID:
22830635
18.

Anti-hepatitis C virus activity and toxicity of type III phosphatidylinositol-4-kinase beta inhibitors.

Lamarche MJ, Borawski J, Bose A, Capacci-Daniel C, Colvin R, Dennehy M, Ding J, Dobler M, Drumm J, Gaither LA, Gao J, Jiang X, Lin K, McKeever U, Puyang X, Raman P, Thohan S, Tommasi R, Wagner K, Xiong X, Zabawa T, Zhu S, Wiedmann B.

Antimicrob Agents Chemother. 2012 Oct;56(10):5149-56. doi: 10.1128/AAC.00946-12. Epub 2012 Jul 23.

19.

[Salivary phosphate-binding chewing gum--an integrative approach to chronic kidney disease and oral diseases].

Wilczyńska-Borawska M, Borawski J, Stokowska W.

Przegl Lek. 2011;68(9):633-6. Review. Polish.

PMID:
22335015
20.

Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy.

Kowalska I, Borawski J, Nikołajuk A, Budlewski T, Otziomek E, Górska M, Strączkowski M.

Endocrine. 2011 Aug;40(1):95-101. doi: 10.1007/s12020-011-9446-5. Epub 2011 Mar 18.

PMID:
21424182
21.

Full-length TFPI release by heparinoid sulodexide.

Borawski J, Naumnik B, Dubowski M, Mysliwiec M.

Clin Appl Thromb Hemost. 2010 Aug;16(4):485-7. doi: 10.1177/1076029609338048. No abstract available.

PMID:
20647229
22.

Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585.

Stühmer T, Arts J, Chatterjee M, Borawski J, Wolff A, King P, Einsele H, Leo E, Bargou RC.

Br J Haematol. 2010 May;149(4):529-36. doi: 10.1111/j.1365-2141.2010.08126.x. Epub 2010 Mar 13.

PMID:
20331455
23.

Multiple cyclophilins involved in different cellular pathways mediate HCV replication.

Gaither LA, Borawski J, Anderson LJ, Balabanis KA, Devay P, Joberty G, Rau C, Schirle M, Bouwmeester T, Mickanin C, Zhao S, Vickers C, Lee L, Deng G, Baryza J, Fujimoto RA, Lin K, Compton T, Wiedmann B.

Virology. 2010 Feb 5;397(1):43-55. doi: 10.1016/j.virol.2009.10.043. Epub 2009 Nov 24.

24.

Hepatocyte growth factor/activin A/follistatin system activation during hemodialysis with different low molecular weight heparins.

Rydzewska-Rosołowska A, Borawski J, Myśliwiec M.

Ren Fail. 2009;31(9):791-7. doi: 10.3109/08860220903180608.

PMID:
19925286
25.

Intravenous and oral sulodexide versus coagulation activation markers in humans.

Borawski J, Dubowski M, Rydzewska-Rosolowska A, Mysliwiec M.

Clin Appl Thromb Hemost. 2009 Oct;15(5):596-8. doi: 10.1177/1076029609333674. No abstract available.

PMID:
19910295
26.

Enoxaparin decreases serum MCP-1 concentration during haemodialysis-preliminary report.

Rydzewska-Rosołowska A, Borawski J, Myśliwiec M.

NDT Plus. 2009 Oct;2(5):429-30. doi: 10.1093/ndtplus/sfp060. No abstract available.

27.

High plasma endostatin level unaffected by low-molecular weight heparin in hemodialysis patients--a preliminary report.

Rydzewska-Rosolowska A, Borawski J, Mysliwiec M.

Adv Med Sci. 2009;54(2):199-202. doi: 10.2478/v10039-009-0030-7.

PMID:
19758969
28.

Tissue factor pathway inhibitor release and depletion by sulodexide in humans.

Borawski J, Gozdzikiewicz J, Dubowski M, Pawlak K, Mysliwiec M.

Adv Med Sci. 2009;54(1):32-6. doi: 10.2478/v10039-009-0009-4.

PMID:
19731406
29.

Class III phosphatidylinositol 4-kinase alpha and beta are novel host factor regulators of hepatitis C virus replication.

Borawski J, Troke P, Puyang X, Gibaja V, Zhao S, Mickanin C, Leighton-Davies J, Wilson CJ, Myer V, Cornellataracido I, Baryza J, Tallarico J, Joberty G, Bantscheff M, Schirle M, Bouwmeester T, Mathy JE, Lin K, Compton T, Labow M, Wiedmann B, Gaither LA.

J Virol. 2009 Oct;83(19):10058-74. doi: 10.1128/JVI.02418-08. Epub 2009 Jul 15.

30.

Effect of sulodexide on plasma transforming growth factor-beta1 in healthy volunteers.

Borawski J, Dubowski M, Pawlak K, Mysliwiec M.

Clin Appl Thromb Hemost. 2010 Feb;16(1):60-5. doi: 10.1177/1076029608326170. Epub 2008 Dec 30.

PMID:
19117965
31.

Cholera toxin, E. coli heat-labile toxin, and non-toxic derivatives induce dendritic cell migration into the follicle-associated epithelium of Peyer's patches.

Anosova NG, Chabot S, Shreedhar V, Borawski JA, Dickinson BL, Neutra MR.

Mucosal Immunol. 2008 Jan;1(1):59-67. doi: 10.1038/mi.2007.7.

32.

Chronic viral hepatitis C, oxidative stress and the coagulation/fibrinolysis system in haemodialysis patients.

Pawlak K, Zolbach K, Borawski J, Mysliwiec M, Kovalchuk O, Chyczewski L, Pawlak D.

Thromb Res. 2008;123(1):166-70. doi: 10.1016/j.thromres.2008.02.012. Epub 2008 May 2.

PMID:
18452978
33.

Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.

Elis W, Triantafellow E, Wolters NM, Sian KR, Caponigro G, Borawski J, Gaither LA, Murphy LO, Finan PM, Mackeigan JP.

Mol Cancer Res. 2008 Apr;6(4):614-23. doi: 10.1158/1541-7786.MCR-07-0262.

34.

Staphylococcal scalded skin syndrome in the course of lupus nephritis.

Rydzewska-Rosołowska A, Brzosko S, Borawski J, Myśliwiec M.

Nephrology (Carlton). 2008 Jun;13(3):265-6. doi: 10.1111/j.1440-1797.2007.00904.x. No abstract available.

PMID:
18315709
35.

Pleiotropic effects of heparin and heparinoids in peritoneal dialysis.

Gozdzikiewicz J, Borawski J, Mysliwiec M.

Clin Appl Thromb Hemost. 2009 Feb;15(1):92-7. Epub 2007 Dec 26. Review.

PMID:
18160609
36.

A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-alpha signaling.

Gaither A, Porter D, Yao Y, Borawski J, Yang G, Donovan J, Sage D, Slisz J, Tran M, Straub C, Ramsey T, Iourgenko V, Huang A, Chen Y, Schlegel R, Labow M, Fawell S, Sellers WR, Zawel L.

Cancer Res. 2007 Dec 15;67(24):11493-8.

37.

Ca2+-dependent calmodulin binding to FcRn affects immunoglobulin G transport in the transcytotic pathway.

Dickinson BL, Claypool SM, D'Angelo JA, Aiken ML, Venu N, Yen EH, Wagner JS, Borawski JA, Pierce AT, Hershberg R, Blumberg RS, Lencer WI.

Mol Biol Cell. 2008 Jan;19(1):414-23. Epub 2007 Nov 14.

38.

Sulodexide for hemodialysis anticoagulation in heparin-induced thrombocytopenia type II.

Borawski J, Zbroch E, Rydzewska-Rosolowska A, Pawlak K, Mysliwiec M.

J Nephrol. 2007 May-Jun;20(3):370-2.

PMID:
17557272
39.

Heparin, myeloperoxidase, and atherosclerosis: a new focus on an old drug.

Borawski J, Naumnik B, Mysliwiec M.

Clin Appl Thromb Hemost. 2007 Apr;13(2):219-20. No abstract available.

PMID:
17456634
40.

Optimization procedure for small interfering RNA transfection in a 384-well format.

Borawski J, Lindeman A, Buxton F, Labow M, Gaither LA.

J Biomol Screen. 2007 Jun;12(4):546-59. Epub 2007 Apr 13.

PMID:
17435168
41.

[SEN virus infection in maintenance hemodialysis patients].

Borawski J, Kovalchuk O, Chlebińska I, Naumnik B, Rydzewska-Rosołowska A, Chyczewski L, Myśliwiec M.

Wiad Lek. 2006;59(11-12):751-6. Polish.

PMID:
17427486
42.

Enoxaparin but not unfractionated heparin causes a dose-dependent increase in plasma TGF-beta 1 during haemodialysis: a cross-over study.

Naumnik B, Borawski J, Pawlak K, Mysliwiec M.

Nephrol Dial Transplant. 2007 Jun;22(6):1690-6. Epub 2007 Mar 26.

PMID:
17389624
43.

Sulodexide induces hepatocyte growth factor release in humans.

Borawski J, Dubowski M, Pawlak K, Mysliwiec M.

Eur J Pharmacol. 2007 Mar 8;558(1-3):167-71. Epub 2006 Dec 29.

PMID:
17258198
44.

Treatment of heparin-induced thrombocytopenia type II in hemodialysis patients: the search for a Holy Grail continues.

Goździkiewicz J, Borawski J, Myśliwiec M.

Clin Appl Thromb Hemost. 2007 Jan;13(1):110-1. No abstract available.

PMID:
17164502
45.

[Relevance of some growth factors to cardiovascular disease in maintenance hemodialysis patients].

Borawski J, Myśliwiec M.

Pol Merkur Lekarski. 2006 Aug;21(122):117-8; discussion 119. Polish.

PMID:
17144092
46.

The periodontal status of pre-dialysis chronic kidney disease and maintenance dialysis patients.

Borawski J, Wilczyńska-Borawska M, Stokowska W, Myśliwiec M.

Nephrol Dial Transplant. 2007 Feb;22(2):457-64. Epub 2006 Nov 23.

PMID:
17124280
47.

TGF-beta1 and endothelial/tissue injury with high-dose intravenous iron therapy in renal failure: evidence or perception?

Goździkiewicz J, Borawski J, Naumnik B, Rydzewska-Rosołowska A, Pawlak K, Myśliwiec M.

Clin Appl Thromb Hemost. 2006 Oct;12(4):493-4. No abstract available.

PMID:
17000896
48.

Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.

Naumnik B, Borawski J, Chyczewski L, Pawlak K, Mysliwiec M.

Nephrol Dial Transplant. 2006 Dec;21(12):3450-7. Epub 2006 Sep 17.

PMID:
16982632
49.

Hepatocyte growth factor in saliva is a potential marker of symptomatic periodontal disease.

Wilczynska-Borawska M, Borawski J, Kovalchuk O, Chyczewski L, Stokowska W.

J Oral Sci. 2006 Jun;48(2):47-50.

50.

Modulation of hematopoiesis by ketanserin in erythropoietin-treated uremic patients: evidence from platelet studies.

Borawski J, Rydzewski A, Azzadin A, Buczko W, Mysliwiec M.

Platelets. 1998;9(1):31-5.

PMID:
16793742

Supplemental Content

Loading ...
Support Center